Symposia

NCS_514537-20_VirtualAM_Web_Graphics_Update_1140x288_r1

Industry-sponsored Symposia

Join NCS sponsors for sessions surrounding the latest neurcritical care practices and technologies. Breakfast or lunch will be provided to the first 150 attendees at each symposia.

Tuesday, September 22

2:00 p.m. – 2:50 p.m. EDT

UCB_LOGO_TAG_ReflexBlue_CMYK_v.png

Selecting the Right Ready-to-use IV Antihypertensive in an Unpredictable Market

David Rose, MD  


Wednesday, September 23

3:00 p.m. – 3:50 p.m. EDT

a_sig_vert_2c_bk_jpg.jpg

Elevating Focal-seizure Management in Critical Care

Paul Vespa, MD, FCCM, FAAN, FANA, FNCS, Henrik Klitgaard, PhD, Denise H. Rhoney, PharmD

Log on to hear from three experts to better understand the risks of seizures in critically ill patients and learn more about an antiseizure treatment option for adult patients with partial-onset seizures.

Thursday, September 24

2:00 p.m. – 2:50 p.m. EDT
NeurOptics_Logo_web.jpg

Delivering TTM to Every Patient That Needs It; When It Matters Most

A Scientifically Nuanced Look at 36°c or 33°c: Which Temperature I Would Prefer If I Were the Patient?
Romergryko G. Geocadin, MD, FNCS, FANA, FAAN

Moving Targeted Temperature Management from Science into Practice.
Rick L. Rettke Jr, BSN, TNCC, CCRN-CSC

Friday, September 25

10:00 a.m. – 10:50 a.m. EDT
NeurOptics_Logo_web.jpg

Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)

Shaun Keegan, PHARMD